Haemonetics (HAE) Tops Q3 EPS by 3c; Sees FY17 Outlook at High End of Range

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Haemonetics (HAE) Tops Q3 EPS by 3c; Sees FY17 Outlook at High End of Range

Barrington Research Downgrades Haemonetics (HAE) to Market Perform

February 7, 2017 9:33 AM EST

Barrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform and removed its price target (prior $41.00).

For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.

Shares of Haemonetics closed at $38.00 yesterday.

... More